---
schema_version: "secwatch.filing_event.v1"
accession: "0001096906-22-000130"
form_type: "8-K"
ticker: "AIBT"
cik: "0001763329"
company_name: "AIBOTICS, INC."
filed_at: "2022-01-14T23:59:59+00:00"
generated_at: "2026-06-27T17:59:16.617900+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Mycotopia Therapies appoints Benjamin Kaplan as CEO; $24k/mo consulting fee, 5% equity warrants

## Summary
- CEO appointment effective Jan 19, 2021; initial 36-month term with automatic 12-month renewal.
- Monthly consulting fee of $24,000; expense allowance of $7,000 per month; disability insurance provided.
- Equity compensation includes warrants for 5% of fully diluted shares as bonus milestones and a 5% stock grant on significant transactions.
- Termination without cause triggers a severance equal to three years of total compensation (fees, bonuses, equity grants, insurance).
- Agreement includes standard non-compete, non-solicitation, and confidentiality covenants.

## SEC filing metadata
- accession: 0001096906-22-000130
- form_type: 8-K
- ticker: AIBT
- cik: 0001763329
- company_name: AIBOTICS, INC.
- filed_at: 2022-01-14T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1763329/000109690622000130/0001096906-22-000130-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1763329/000109690622000130/tpia-20211117.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001096906-22-000130
- JSON: https://secwatch.observer/filing/0001096906-22-000130.json
- Plain text: https://secwatch.observer/filing/0001096906-22-000130.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.